Pt had vomiting after eating loss of appetite and low grade fever tell me Diff diagnosis
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
I now have excellent source material from Goldman-Cecil Medicine and Tintinalli's Emergency Medicine. Let me compile a thorough differential diagnosis.
Differential Diagnosis: Vomiting After Eating + Loss of Appetite + Low-Grade Fever
This triad - postprandial vomiting, anorexia, and low-grade fever - points to a range of conditions, primarily GI but extending to systemic disease. Below is an organized differential from most to less common, grounded in textbook sources.
1. Acute Gastroenteritis (Most Common)
- Viral (Norovirus, Rotavirus): sudden onset, vomiting ± diarrhea, low-grade fever, self-limited (<7 days). Most likely diagnosis in otherwise healthy patients.
- Bacterial (Salmonella, Campylobacter, E. coli): similar picture but with higher fever, crampy abdominal pain, and often diarrhea. Food history is key.
- Note: isolated vomiting without diarrhea should NOT be called gastroenteritis - the differential is broader in that setting.
- Source: Tintinalli's Emergency Medicine, p. 887
2. Acute Appendicitis
- Classic triad: periumbilical pain migrating to RLQ, anorexia, nausea/vomiting, low-grade fever (fever is typically a late sign).
- Vomiting usually follows pain onset (pain comes first - if vomiting precedes pain, think gastroenteritis).
- Associated with elevated WBC; diagnose with ultrasound or CT.
- Source: Goldman-Cecil Medicine, Table 118-2
3. Acute Cholecystitis / Biliary Colic
- Postprandial vomiting, especially after fatty meals.
- RUQ or epigastric pain radiating to right scapula, nausea, vomiting, low-grade fever.
- Murphy's sign positive on exam; elevated WBC; diagnose with abdominal ultrasound.
- Source: Goldman-Cecil Medicine, Table 118-2
4. Acute Pancreatitis
- Epigastric pain radiating to the back, severe nausea and vomiting, anorexia, low-grade or high fever depending on severity.
- Associated with alcohol use or gallstones; elevated serum amylase and lipase.
- Pain is aggravated by food.
- Source: Goldman-Cecil Medicine, Table 118-2
5. Peptic Ulcer Disease / Gastritis
- Epigastric burning/discomfort, postprandial nausea and vomiting, anorexia.
- Low-grade fever is less typical but can occur with Helicobacter pylori-associated gastritis.
- Common with NSAID use or H. pylori infection.
- Source: Goldman-Cecil Medicine, Table 118-2
6. Viral Hepatitis (A, E especially)
- Prodromal phase: anorexia, fatigue, nausea, vomiting, low-grade fever - often before jaundice appears.
- Hepatitis A and E are foodborne; onset after eating contaminated food is classic.
- RUQ tenderness, elevated liver enzymes.
7. Typhoid Fever (Enteric Fever)
- Sustained or stepwise low-grade fever, anorexia, nausea, vomiting, constipation or diarrhea, rose spots.
- From Salmonella typhi/paratyphi; endemic areas or travel history.
8. Food Poisoning (Toxin-mediated)
- Staphylococcal toxin: very rapid onset (1-6 hrs after eating), profuse vomiting, no or minimal fever.
- B. cereus emetic form: similar rapid onset.
- C. perfringens: 8-16 hrs after meat, diarrhea + vomiting, mild fever.
- Typically short-lived (< 24 hours).
9. Diverticulitis
- LLQ pain, anorexia, nausea, low-grade fever, constipation or diarrhea.
- More common in older adults; diagnose with CT.
- Source: Goldman-Cecil Medicine, Table 118-2
10. Urinary Tract Infection / Pyelonephritis
- Fever, nausea, vomiting, and anorexia can occur - especially pyelonephritis.
- Look for dysuria, flank pain, costovertebral angle tenderness.
- Urine dipstick and culture confirm diagnosis.
11. Mesenteric Adenitis
- Common in children and young adults; inflamed mesenteric lymph nodes (often post-viral).
- Mimics appendicitis but with less localized pain, low-grade fever, vomiting, anorexia.
- Diagnosed by excluding appendicitis on imaging.
12. Bowel Obstruction (partial)
- Nausea, vomiting, anorexia, colicky pain; fever appears late or with strangulation.
- Abdominal distention, high-pitched or absent bowel sounds.
- Source: Goldman-Cecil Medicine, Table 118-2
13. Less Common but Important
| Condition | Key Distinguishing Feature |
|---|---|
| Ectopic pregnancy | Female of reproductive age, missed period, unilateral pain |
| Pelvic Inflammatory Disease (PID) | Women, pelvic pain, cervical motion tenderness |
| Meningitis | Headache, neck stiffness, photophobia with vomiting + fever |
| Inferior MI | Epigastric pain, vomiting, in older/diabetic patients |
| Adrenal crisis | Salt craving, hypotension, profound weakness |
| Cyclospora/Cystoisospora infection | Watery diarrhea, nausea, anorexia, travel history |
Approach to Narrow the Differential
Ask about:
- Timing of vomiting relative to meals (immediately = gastric outlet/pyloric, 1-4 hrs = motility)
- Associated pain - location, character (RLQ = appendicitis, RUQ = biliary, epigastric = PUD/pancreatitis)
- Diarrhea - its presence or absence strongly shapes the differential
- Food/travel history (food poisoning, typhoid, hepatitis A/E)
- Urine symptoms (UTI/pyelonephritis)
- Jaundice (hepatitis)
- Menstrual history in women (ectopic pregnancy, PID)
Key initial workup: CBC, CRP, LFTs, amylase/lipase, urine analysis, abdominal ultrasound.
Viral hepatities proper investigation and manent
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Excellent - I now have comprehensive, textbook-sourced information. Here is the full answer:
Viral Hepatitis: Investigations & Management
(Sources: Goldman-Cecil Medicine, Textbook of Family Medicine 9e, Henry's Clinical Diagnosis and Management by Laboratory Methods)
PART 1 - INVESTIGATIONS
A. Liver Function Tests (LFTs) - First Line
| Test | Finding in Viral Hepatitis |
|---|---|
| ALT (SGPT) | Markedly elevated (>200 IU/L, often 500-1000+) - cardinal finding |
| AST (SGOT) | Elevated; ALT usually higher than AST (ALT:AST ratio >1) |
| Serum Bilirubin | Elevated - both direct and indirect fractions |
| ALP | Mildly elevated (~200-350 IU/L) |
| PT/INR | Prolonged in severe disease - alarm sign |
| Albumin/Total Protein | Usually normal unless fulminant failure |
| LDH | Mildly elevated (~300-500 IU/L) |
Alarm signs of severe hepatic destruction: hepatic encephalopathy (mental status changes), asterixis, ascites, prolonged PT.
B. Specific Serological Markers (the KEY investigations)
Hepatitis A (HAV)
| Marker | Meaning |
|---|---|
| Anti-HAV IgM | Acute/recent infection - appears at symptom onset, resolves within 1 year |
| Anti-HAV IgG | Past infection / immunity (negative IgM + positive IgG = past exposure) |
Hepatitis B (HBV)
| Marker | Meaning |
|---|---|
| HBsAg | Earliest indicator of acute HBV; persists >6 months = chronic carrier |
| Anti-HBs | Recovery and immunity; appears after HBsAg disappears |
| IgM Anti-HBc | Best test to confirm acute active HBV infection (short-lived, 3-6 weeks) |
| Total Anti-HBc | Lifelong marker of past exposure (does not confer immunity) |
| HBeAg | Active replication - highly contagious |
| Anti-HBe | Seroconversion - indicates low infectivity / resolution |
| HBV DNA | Quantitative viral load (used to guide treatment decisions) |
HBV serological patterns by phase:
| Phase | HBsAg | IgM Anti-HBc | Anti-HBs |
|---|---|---|---|
| Incubation | + | +/- | - |
| Acute hepatitis | + | + | - |
| Convalescence | - | + | - |
| Recovery | - | - | + |
Hepatitis C (HCV)
| Marker | Meaning |
|---|---|
| Anti-HCV antibody | Appears 3-12 months after exposure - screening test |
| HCV RNA (PCR) | Confirms active infection; used for treatment monitoring |
| HCV genotype | Guides choice and duration of antiviral therapy |
Hepatitis D (HDV)
- Anti-HDV antibody - may appear late and be short-lived; only occurs in HBV-infected patients (requires HBsAg)
Hepatitis E (HEV)
- No routine commercial markers; diagnosis is largely clinical/epidemiological
- Epidemiology parallels HAV (fecal-oral, waterborne)
C. Additional Workup
| Investigation | Purpose |
|---|---|
| CBC | Leukopenia common in viral hepatitis; helps rule out other causes |
| Blood glucose | Hypoglycemia risk in fulminant hepatic failure |
| Serum creatinine/electrolytes | Baseline; hepatorenal syndrome in severe cases |
| Abdominal ultrasound | Hepatomegaly, rule out biliary obstruction, assess liver echogenicity |
| ANA, anti-smooth muscle Ab | Rule out autoimmune hepatitis (if viral screen negative) |
| Ceruloplasmin + urine copper | Rule out Wilson disease in young patients |
| EBV, CMV serology | If viral hepatitis A/B/C screen negative |
| Liver biopsy | Not needed for acute hepatitis; considered in chronic disease staging |
PART 2 - MANAGEMENT
General Principles (All Types of Acute Viral Hepatitis)
- Most acute viral hepatitis is self-limiting - managed as outpatient with supportive care
- Rest - allow slow return to usual activity as symptoms improve
- Nutrition - adequate caloric intake; small frequent meals if nausea is prominent
- Hydration - maintain fluid intake; IV fluids if oral intake is poor
- Avoid hepatotoxic drugs - no alcohol, NSAIDs, acetaminophen, or unnecessary medications
- Contact isolation precautions - educate patient and household contacts
- Symptomatic improvement typically precedes normalization of liver enzymes
- Hospitalization indications: hepatic encephalopathy, coagulopathy (elevated PT), severe dehydration, bilirubin very high, or inability to tolerate oral intake
Hepatitis A - Specific Management
- No antiviral treatment - purely supportive
- Post-exposure prophylaxis: immune globulin (IG) given during known incubation period
- Vaccination: HAV vaccine recommended for high-risk groups and household contacts
- Recovery is complete; no chronic carrier state
Hepatitis B - Specific Management
Acute HBV:
- Generally does NOT require antiviral treatment
- Antivirals (entecavir or tenofovir) indicated in severe acute HBV: coagulopathy, encephalopathy
- Dose: entecavir 0.5 mg/day or tenofovir disoproxil fumarate 300 mg/day
Chronic HBV - Treatment Criteria:
- HBsAg positive >6 months
- HBV DNA >2000 IU/mL (HBeAg-negative) or >20,000 IU/mL (HBeAg-positive)
- ALT >2x upper limit of normal
Preferred Antivirals for Chronic HBV:
| Drug | Dose | Route |
|---|---|---|
| Tenofovir disoproxil fumarate (TDF) | 300 mg/day | PO |
| Tenofovir alafenamide (TAF) | 25 mg/day | PO |
| Entecavir (naive) | 0.5 mg/day | PO |
| Entecavir (lamivudine-resistant) | 1 mg/day | PO |
| PEG-Interferon alfa-2a | 180 mcg/week x 48 weeks | SC |
| Lamivudine | 100 mg/day | PO |
- HBeAg-positive: treat until HBeAg seroconversion + undetectable HBV DNA + 6 more months
- HBeAg-negative: treat for at least 1 year
- Decompensated cirrhosis or post-transplant: lifelong treatment
Prevention:
- Vaccination: 3 doses at 0, 1, and 6 months; anti-HBs >10 IU/L = protective
- Post-exposure: Hepatitis B Immunoglobulin (HBIG) 0.06 mL/kg IM within 96 hours + vaccine series
Hepatitis C - Specific Management
Acute HCV: Treatment is symptomatic; antivirals generally NOT indicated acutely
Chronic HCV - Goal: Sustained Virologic Response (SVR) = undetectable HCV RNA 12+ weeks after treatment
Direct-Acting Antivirals (DAAs) - Pan-genotypic regimens:
| Regimen | Brand | Genotypes |
|---|---|---|
| Sofosbuvir/velpatasvir | Epclusa | 1-6 (all) |
| Glecaprevir/pibrentasvir | Mavyret | 1-6 (all) |
| Ledipasvir/sofosbuvir | Harvoni | 1, 4, 5, 6 |
| Sofosbuvir/velpatasvir/voxilaprevir | Vosevi | 1-6 (salvage) |
- Duration: typically 8-12 weeks (±24 weeks in cirrhosis)
- DAA therapy achieves cure rates >95%
- No post-exposure prophylaxis available for HCV
Hepatitis D
- Only occurs as coinfection or superinfection with HBV
- Treatment: PEG-Interferon (limited efficacy)
- Prevention: HBV vaccination prevents HDV
Hepatitis E
- Supportive management only
- Spontaneous resolution in most; high mortality in pregnant women (up to 20%)
- Ribavirin used in immunocompromised patients
- Avoid in pregnancy
Monitoring During Treatment
- LFTs (ALT/AST) monthly
- HBV DNA / HCV RNA to assess viral suppression
- HBeAg/Anti-HBe seroconversion in HBV
- PT/INR and bilirubin if severe disease
- Screen for hepatocellular carcinoma (HCC) with ultrasound + AFP every 6 months in chronic HBV/HCV patients
Sources: Goldman-Cecil Medicine (Chapters 134, 135, 328), Textbook of Family Medicine 9e (Table 38-10), Henry's Clinical Diagnosis and Management by Laboratory Methods
Inj doxy will work on this
Finding Sources
Finding Sources
Reading File
Finding Sources
Will Inj. Doxycycline Work on Viral Hepatitis?
No. Doxycycline will NOT work on viral hepatitis. Here is a clear breakdown of why:
What Doxycycline Is
Doxycycline is a tetracycline-class antibiotic. Its mechanism of action is:
- Binds to the 30S ribosomal subunit of bacteria
- Blocks binding of aminoacyl-tRNA to the ribosome
- This stops bacterial protein synthesis
This mechanism targets a structure found in bacteria only - not in human viruses.
Why It Cannot Work on Viral Hepatitis
| Fact | Explanation |
|---|---|
| Viruses have NO ribosomes | HAV, HBV, HCV, HEV use the host cell's ribosomes - doxycycline cannot block this |
| Doxycycline is antibacterial | It has no antiviral activity whatsoever |
| Hepatitis viruses replicate differently | Each virus has its own specific replication enzymes (e.g., HCV NS5B polymerase, HBV reverse transcriptase) that require specific antivirals |
What's Worse - Doxycycline Can Actually HARM the Liver
From Goldman-Cecil Medicine, doxycycline (a tetracycline derivative) is listed as a cause of drug-induced liver toxicity and vanishing bile duct syndrome. Giving it to a patient who already has hepatitis could:
- Worsen liver inflammation
- Add drug-induced hepatotoxicity on top of viral hepatitis
- This is genuinely dangerous
What Actually Works (Quick Recap)
| Hepatitis Type | Correct Treatment |
|---|---|
| Hep A | Supportive only - no antiviral needed |
| Hep B (acute) | Supportive; antivirals only if severe (entecavir / tenofovir) |
| Hep B (chronic) | Tenofovir, Entecavir, PEG-Interferon |
| Hep C | Direct-acting antivirals - sofosbuvir-based regimens (>95% cure) |
| Hep E | Supportive; ribavirin in immunocompromised |
When IS Doxycycline Used in Liver-Related Infections?
Doxycycline is appropriate for hepatitis caused by bacteria, not viruses:
- Leptospirosis - can cause jaundice + hepatitis (Weil's disease) - doxycycline IS first-line
- Q fever (Coxiella burnetii) - hepatitis-like presentation - doxycycline IS first-line
- Rickettsia infections with liver involvement - doxycycline IS first-line
- Brucellosis with liver involvement - doxycycline IS part of treatment
So if the clinical picture suggests a bacterial/zoonotic cause of hepatitis (travel history, animal exposure, atypical features), doxycycline may have a role - but not in standard viral hepatitis A/B/C/D/E.
Sources: Goldman-Cecil Medicine; Tietz Textbook of Laboratory Medicine, 7th Ed.
Which antibiotic will help in this condition
Finding Sources
Finding Sources
No Antibiotic Works on Viral Hepatitis
This is a very important clinical point:
The Core Principle
Antibiotics work on bacteria. Viral hepatitis is caused by viruses. These are completely different organisms.
| What kills bacteria | What kills viruses |
|---|---|
| Antibiotics (penicillin, doxycycline, ciprofloxacin, etc.) | Antivirals (specific to each virus) |
No antibiotic - whether doxycycline, amoxicillin, ciprofloxacin, azithromycin, or any other - has any activity against hepatitis viruses.
Then What Do You Use?
The correct drug class is antivirals, and they are virus-specific:
| Hepatitis Type | Correct Drug Class | Examples |
|---|---|---|
| Hep A | None needed | Supportive care only - resolves on its own |
| Hep B (chronic) | Nucleoside/nucleotide analogues | Tenofovir, Entecavir |
| Hep B (severe acute) | Same antivirals | Entecavir 0.5 mg/day or Tenofovir 300 mg/day |
| Hep C (chronic) | Direct-acting antivirals (DAAs) | Sofosbuvir/Velpatasvir, Ledipasvir/Sofosbuvir |
| Hep E | Supportive (ribavirin if immunocompromised) | Supportive care |
When ARE Antibiotics Used in Liver Disease?
Antibiotics are only used in two specific liver-related scenarios:
-
Complications of advanced cirrhosis / liver failure:
- Spontaneous Bacterial Peritonitis (SBP) - cefotaxime or piperacillin-tazobactam
- Hepatic encephalopathy - rifaximin (non-absorbed antibiotic that reduces gut ammonia-producing bacteria)
- Secondary bacterial infections complicating liver failure
-
Bacterial infections that MIMIC or CAUSE hepatitis (not true viral hepatitis):
- Leptospirosis - doxycycline or penicillin
- Q fever (Coxiella) - doxycycline
- Brucellosis - doxycycline + rifampicin
- Typhoid fever - ciprofloxacin or azithromycin or ceftriaxone
- Pyogenic liver abscess - metronidazole + broad-spectrum antibiotics
Bottom Line
If the diagnosis is viral hepatitis A, B, C, D, or E - prescribing any antibiotic is not only useless but potentially harmful (hepatotoxic risk). The correct treatment is supportive care for acute disease, and specific antivirals (tenofovir, entecavir, sofosbuvir) for chronic HBV/HCV.
Always clarify the exact cause before prescribing. If bacterial hepatitis (leptospirosis, typhoid, brucellosis) is in the differential, then the appropriate antibiotic for that specific bacterium is indicated - not a broad guess.
Bacterial hepatitis
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Excellent - very rich textbook data. Now compiling a comprehensive answer.
Bacterial Hepatitis: Causes, Features, Investigations & Treatment
(Sources: Tintinalli's Emergency Medicine, Sleisenger & Fordtran's GI & Liver Disease, Mulholland & Greenfield's Surgery)
What is Bacterial Hepatitis?
Bacterial hepatitis = liver inflammation caused by bacterial infection. It can occur by:
- Direct bacterial invasion of the liver (abscess, spirochetes)
- Systemic bacteremia seeding the liver (typhoid, sepsis)
- Toxin/endotoxin-mediated hepatocyte damage (gram-negative sepsis)
- Perihepatitis - inflammation of the liver capsule (Fitz-Hugh-Curtis)
Major Causes and Specific Antibiotic Treatment
1. Leptospirosis (Weil's Disease)
Most important cause of bacterial hepatitis worldwide
| Feature | Detail |
|---|---|
| Organism | Leptospira interrogans (spirochete) |
| Transmission | Contact with freshwater contaminated by rodent/animal urine; flooding outbreaks |
| Incubation | 2 days - 4 weeks |
| Clinical features | Biphasic illness - Phase 1: fever, severe headache, myalgia, conjunctival injection, hepatitis; Phase 2 (Weil's disease): jaundice, renal failure, aseptic meningitis, uveitis, circulatory collapse |
| Diagnosis | Serology (MAT - microscopic agglutination test); blood/urine culture |
| Key labs | Elevated bilirubin, ALT/AST, creatinine; leukocytosis |
Treatment:
| Severity | Drug | Dose | Duration |
|---|---|---|---|
| Mild | Doxycycline PO | 100 mg BD | 7 days |
| Mild (alt) | Amoxicillin PO | 500 mg TDS | 7 days |
| Severe | Penicillin G IV | 1.5 MU every 6 hrs | 7 days |
| Severe (alt) | Ceftriaxone IV | 1g/day | 7 days |
| Severe (alt) | Ampicillin IV | 500-1000 mg every 6 hrs | 7 days |
So YES - doxycycline IS indicated here (mild leptospirosis)
2. Typhoid Fever (Enteric Fever with Hepatic Involvement)
Salmonella Typhi - commonly affects the liver
| Feature | Detail |
|---|---|
| Organism | Salmonella Typhi/Paratyphi |
| Liver involvement | Elevated ALT/AST (very common), jaundice in minority, tender hepatomegaly, typhoid nodules (Kupffer cell hyperplasia) |
| Severe form | Jaundice + encephalopathy (AST > ALT, elevated ALP, thrombocytopenia) |
| Complications | Cholecystitis, liver abscess |
| Mortality | Up to 20% if delayed treatment |
Treatment:
| Drug | Route | Note |
|---|---|---|
| Ceftriaxone | IV | First-line |
| Ciprofloxacin | PO/IV | Where resistance is uncommon |
| Azithromycin | PO | For uncomplicated typhoid |
3. Pyogenic Liver Abscess
Bacterial pus collection within liver parenchyma
| Feature | Detail |
|---|---|
| Organisms | E. coli, Klebsiella, Staphylococcus, Streptococcus, anaerobes (often mixed) |
| Source | Biliary tract disease (most common), portal vein bacteremia, direct spread |
| Clinical | Fever, RUQ pain, jaundice, tender hepatomegaly, leukocytosis |
| Diagnosis | Ultrasound or CT abdomen (collection with rim enhancement) |
Treatment:
- Broad-spectrum antibiotics (empirical coverage of gram-negatives + anaerobes):
- Piperacillin-tazobactam IV (first choice)
- Ceftriaxone + metronidazole IV
- Imipenem/meropenem for severe/resistant cases
- Percutaneous image-guided drainage for large abscesses
- Rarely: surgical drainage
4. Q Fever (Coxiella burnetii)
| Feature | Detail |
|---|---|
| Organism | Coxiella burnetii (intracellular bacterium) |
| Transmission | Inhalation of aerosols from infected animals (cattle, sheep, goats) |
| Liver | Granulomatous hepatitis - classic "doughnut granuloma" on biopsy |
| Clinical | Fever, hepatomegaly, elevated LFTs |
| Treatment | Doxycycline 100 mg BD x 14-21 days (first-line) |
5. Brucellosis
| Feature | Detail |
|---|---|
| Organism | Brucella spp. |
| Transmission | Unpasteurized dairy products, animal contact |
| Liver | Granulomatous hepatitis, hepatosplenomegaly |
| Treatment | Doxycycline 100 mg BD + Rifampicin 600-900 mg/day x 6 weeks |
6. Rickettsia (Rocky Mountain Spotted Fever / Scrub Typhus)
| Feature | Detail |
|---|---|
| Liver | Hepatitis common as part of systemic illness |
| Treatment | Doxycycline 100 mg BD - first-line for ALL rickettsial infections |
7. Fitz-Hugh-Curtis Syndrome (Perihepatitis)
| Feature | Detail |
|---|---|
| Organism | Neisseria gonorrhoeae or Chlamydia trachomatis |
| Mechanism | Direct spread from pelvis to liver capsule |
| Clinical | RUQ pain + signs of PID in women; "violin string" adhesions |
| Treatment | Ceftriaxone + Doxycycline + Metronidazole (per PID guidelines) |
8. Sepsis-Associated Hepatitis
- Any gram-negative sepsis (E. coli, Klebsiella, Pseudomonas) can cause hepatitis via endotoxin
- Treat the underlying source of sepsis with appropriate antibiotics
- Often: piperacillin-tazobactam or carbapenems empirically
Summary Table: Antibiotic of Choice
| Condition | First-Line Antibiotic |
|---|---|
| Leptospirosis (mild) | Doxycycline 100 mg BD x 7 days |
| Leptospirosis (severe) | Penicillin G IV or Ceftriaxone IV |
| Typhoid hepatitis | Ceftriaxone IV (or ciprofloxacin) |
| Pyogenic liver abscess | Pip-tazo or Ceftriaxone + Metronidazole |
| Q fever hepatitis | Doxycycline x 14-21 days |
| Brucellosis | Doxycycline + Rifampicin x 6 weeks |
| Rickettsial hepatitis | Doxycycline |
| Fitz-Hugh-Curtis | Ceftriaxone + Doxycycline |
Key Clinical Point
When a patient presents with fever + hepatitis, always ask: is this truly viral, or could it be bacterial? Clues pointing to bacterial hepatitis:
- Animal/water exposure history (leptospirosis, brucellosis, Q fever)
- Travel to endemic area (typhoid)
- RUQ abscess on imaging (pyogenic abscess)
- Pelvic symptoms in women (Fitz-Hugh-Curtis)
- Negative viral hepatitis serology
Sources: Tintinalli's Emergency Medicine, p. 3430-3433; Sleisenger & Fordtran's GI & Liver Disease, pp. 982-1004; Mulholland & Greenfield's Surgery, p. 1961
This is a shared conversation. Sign in to Orris to start your own chat.